Why the study?
Many patients with PAD have undiagnosed obstructive CAD, and identifying those with lifestyle-limiting claudication without cardiac symptoms who require coronary revascularization using hsTnT remains unestablished.
Does elevated baseline hsTnT predict cardiac events in asymptomatic patients with claudication undergoing elective endovascular treatment?
Does elevated baseline hsTnT predict cardiac events in asymptomatic patients with claudication undergoing elective endovascular treatment?
Answers are grounded in this paper and cite their sources.
Elevated hsTnT in cardiac asymptomatic patients with claudication identifies a high-risk subgroup that may benefit from further cardiac work-up and closer surveillance.
Many patients with peripheral arterial disease (PAD) exhibit undiagnosed obstructive coronary artery disease. We aim to identify the patients with lifestyle limiting claudication due to PAD and without cardiac symptoms, requiring coronary revascularization based on high-sensitive troponin T (hsTnT) values. We assessed hsTnT in consecutive patients referred for elective endovascular treatment due to claudication [Rutherford categories (RC) 2 & 3] between January 2018 and December 2021. Diagnostic work-up by non-invasive imaging and, if required, cardiac catheterization was performed according to clinical data, ECG findings and baseline hsTnT. The occurrence of cardiac death, myocardial infarction or urgent revascularization during follow-up was the primary endpoint. Of 346 patients, 14 (4.0%) exhibited elevated hsTnT ≥ 14 ng/L, including 7 (2.0%) with acute myocardial injury by serial hsTnT sampling. Coronary revascularization by percutaneous coronary intervention was necessary in 6 of 332 (1.5%) patients with normal versus nine of 14 (64.3%) patients with elevated hsTnT (p < 0.001). During 2.4 ± 1.4 years of follow-up, 20 of 286 (7.0%) patients with normal versus four of 13 (30.8%) with elevated hsTnT at baseline reached the composite primary endpoint (p = 0.03 by log-rank test). In conclusion, elevated troponins in cardiac asymptomatic patients with claudication modify subsequent cardiac management and may increase the need for closer surveillance and more aggressive conservative management in polyvascular disease.
No takes yet. Share an insight, caveat, or question.
Mouselimis et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: